- Home
- CELC vs ABM Comparison
CELC vs ABM Comparison
Compare CELC & ABM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CELC | ABM |
|---|---|---|
| Founded | 2011 | 1909 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Diversified Commercial Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.8B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | CELC | ABM |
|---|---|---|
| Price | $103.68 | $46.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $100.13 | $55.25 |
| AVG Volume (30 Days) | ★ 959.5K | 482.2K |
| Earning Date | 11-12-2025 | 12-17-2025 |
| Dividend Yield | N/A | ★ 2.27% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.84 |
| Revenue | N/A | ★ $8,627,900,000.00 |
| Revenue This Year | N/A | $5.43 |
| Revenue Next Year | N/A | $3.15 |
| P/E Ratio | ★ N/A | $25.29 |
| Revenue Growth | N/A | ★ 4.27 |
| 52 Week Low | $7.58 | $40.00 |
| 52 Week High | $112.64 | $56.83 |
Technical Indicators
Market Signals| Indicator | CELC | ABM |
|---|---|---|
| Relative Strength Index (RSI) | 63.75 | 69.05 |
| Support Level | $100.00 | $44.14 |
| Resistance Level | $112.64 | $44.72 |
| Average True Range (ATR) | 5.11 | 0.81 |
| MACD | -1.00 | 0.50 |
| Stochastic Oscillator | 36.57 | 83.67 |
Price Performance
Historical ComparisonAbout CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About ABM ABM Industries Incorporated
ABM Industries Inc is a provider of integrated facility solutions. It offers its solutions through five segments: Business and Industry, Manufacturing and Distribution, Education, Aviation and Technical solutions. The company derives the majority of its revenue from the business and industry segment, which encompasses janitorial, facilities engineering, and parking services for commercial real estate properties and sports and entertainment venues, hospitals, as well as vehicle maintenance and other services to rental car providers. The company mainly operates in the United States of America.